NSE
Lincoln Pharmaceuticals LimitedLINCOLN
Lincoln Pharmaceuticals Limited is an NSE-listed company (LINCOLN).
AI-generated overview — verify before relying on it.
Net institutional flow
+₹10 Cr
Institutional buyers
1 in / 0 out
High-impact filings
0 · tilt Neutral
Next corporate action
—
Competitive landscape — the read
vs most-traded names| # | Company | Inst. flow ₹Cr | Deals | Hi-impact | Filing mom. | Buzz | News |
|---|---|---|---|---|---|---|---|
| 1 | MTNL | +₹41.3 Cr | 331 | — | — | — | — |
| 2 | LINCOLNThis | +₹10 Cr | 17 | — | — | — | — |
| 3 | ATALREAL | +₹7.4 Cr | 363 | — | — | — | — |
| 4 | GATECH | +₹0.4 Cr | 298 | — | — | — | — |
| 5 | IRMENERGY | −₹2.2 Cr | 356 | — | — | — | — |
| 6 | QUADFUTURE | −₹9 Cr | 571 | — | — | — | — |
| 7 | MOBIKWIK | −₹150.9 Cr | 975 | — | — | — | — |
Ranked by net institutional flow (buys − sells, ₹Cr). Filing momentum = bullish − bearish filings; Buzz = news+social sentiment. Curate peers in the company admin.
Timeline — LINCOLN day by day
- 2026-04-29BulkSELL · ₹14.8 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2026-04-29BulkBUY · ₹14.7 CrNK SECURITIES RESEARCH PRIVATE LIMITED
- 2026-04-29BulkSELL · ₹7.6 CrQE SECURITIES LLP
- 2026-04-29BulkBUY · ₹7.7 CrQE SECURITIES LLP
Merged from deals, filings, corporate actions and news — newest first. Scope the deal/action portion with the period chips below.
Filings that matter
No scored filings for LINCOLN yet.
4 deals · 2026-04-29 → 2026-04-29
| Date | Counterparty | Investor type | Side | Value |
|---|---|---|---|---|
| 2026-04-29 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | SELL | ₹14.8 Cr |
| 2026-04-29 | NK SECURITIES RESEARCH PRIVATE LIMITED | Prop / churn | BUY | ₹14.7 Cr |
| 2026-04-29 | QE SECURITIES LLP | Prop / churn | SELL | ₹7.6 Cr |
| 2026-04-29 | QE SECURITIES LLP | Prop / churn | BUY | ₹7.7 Cr |
4 deals in the selected window — corporate actions are scoped to the same period. ~2 years of history available.
News & chatter on LINCOLN
RSS News
0No recent news.
Google News RSS — links open the source.
The Dispatch
0No articles yet.
Our coverage.
No Reddit chatter.
r/ posts mentioning the company.
Twitter / X
0No posts.
Posts mentioning the company.